Anistreplase
"Anistreplase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acylated inactive complex of streptokinase and human lysine-plasminogen. After injection, the acyl group is slowly hydrolyzed, producing an activator that converts plasminogen to plasmin, thereby initiating fibrinolysis. Its half-life is about 90 minutes compared to 5 minutes for TPA; (TISSUE PLASMINOGEN ACTIVATOR); 16 minutes for UROKINASE-TYPE PLASMINOGEN ACTIVATOR and 23 minutes for STREPTOKINASE. If treatment is initiated within 3 hours of onset of symptoms for acute myocardial infarction, the drug preserves myocardial tissue and left ventricular function and increases coronary artery patency. Bleeding complications are similar to other thrombolytic agents.
Descriptor ID |
D016255
|
MeSH Number(s) |
D08.811.277.656.300.760.635.075 D08.811.277.656.300.775.075 D08.811.277.656.959.350.635.075 D12.776.124.125.662.537.075
|
Concept/Terms |
Anistreplase- Anistreplase
- APSAC
- Anisoylated Plasminogen-Streptokinase Activator Complex
Iminase- Iminase
- Madaus Brand of Anistreplase
- Anistreplase Madaus Brand
Eminase- Eminase
- SmithKline Beecham Brand of Anistreplase
- Roberts Brand of Anistreplase
- Anistreplase Roberts Brand
- Monmouth Brand Anistreplase
- Anistreplase, Monmouth Brand
- Brand Anistreplase, Monmouth
- Reusch Brand of Anistreplase
- Anistreplase Reusch Brand
|
Below are MeSH descriptors whose meaning is more general than "Anistreplase".
Below are MeSH descriptors whose meaning is more specific than "Anistreplase".
This graph shows the total number of publications written about "Anistreplase" by people in UAMS Profiles by year, and whether "Anistreplase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Anistreplase" by people in Profiles over the past ten years.